ROCKVILLE, Md.— New findings show that the medication known as Wegovy® (semaglutide) can reduce existing heart disease in patients with obesity by 20%, according to a study co-authored by past ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback